Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James A Hendrix

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 22, 2015
The Worldwide Alzheimer's Disease Neuroimaging Initiative: An updateJames A Hendrix, Brad Finger, Michael W Weiner, et al.
Journal of Patient-Reported Outcomes|January 11, 2021
Development of a symptom menu to facilitate Goal Attainment Scaling in adults with Down syndrome-associated Alzheimer's disease: a qualitative study to identify meaningful symptomsKari Knox, Justin Stanley, James A Hendrix, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2016
Guidelines to improve animal study design and reproducibility for Alzheimer's disease and related dementias: For funders and researchersHeather M Snyder, Diana W Shineman, Lauren G Friedman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 15, 2018
Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's diseaseLeslie M Shaw, Jalayne Arias, Kaj Blennow, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 29, 2016
Challenges, solutions, and recommendations for Alzheimer's disease combination therapyJames A Hendrix, Randall J Bateman, H Robert Brashear, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2013
Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I)Zhongli Gao, William J Hurst, Etienne Guillot, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2013
Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part II)Zhongli Gao, William J Hurst, Etienne Guillot, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 12, 2020
Advancing combination therapy for Alzheimer's diseaseStephen P Salloway, Jeff Sevingy, Kumar Budur, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2018
Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trialsMichael Gold, Joan Amatniek, Maria C Carrillo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 8, 2016
Tau: From research to clinical developmentDavid M Holtzman, Maria C Carrillo, James A Hendrix, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 22, 2015
The Worldwide Alzheimer's Disease Neuroimaging Initiative: An updateJames A Hendrix, Brad Finger, Michael W Weiner, et al.
Journal of Patient-Reported Outcomes|January 11, 2021
Development of a symptom menu to facilitate Goal Attainment Scaling in adults with Down syndrome-associated Alzheimer's disease: a qualitative study to identify meaningful symptomsKari Knox, Justin Stanley, James A Hendrix, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2016
Guidelines to improve animal study design and reproducibility for Alzheimer's disease and related dementias: For funders and researchersHeather M Snyder, Diana W Shineman, Lauren G Friedman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 15, 2018
Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's diseaseLeslie M Shaw, Jalayne Arias, Kaj Blennow, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 29, 2016
Challenges, solutions, and recommendations for Alzheimer's disease combination therapyJames A Hendrix, Randall J Bateman, H Robert Brashear, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2013
Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I)Zhongli Gao, William J Hurst, Etienne Guillot, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2013
Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part II)Zhongli Gao, William J Hurst, Etienne Guillot, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 12, 2020
Advancing combination therapy for Alzheimer's diseaseStephen P Salloway, Jeff Sevingy, Kumar Budur, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2018
Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trialsMichael Gold, Joan Amatniek, Maria C Carrillo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 8, 2016
Tau: From research to clinical developmentDavid M Holtzman, Maria C Carrillo, James A Hendrix, et al.
Pageof 3